Screener
Enovis ENOV R&D
R&D at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Enovis in its filing.
Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.
The source filing: Enovis’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 6:45 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001420800-26-000035
| Line item | Three Months Ended / July 3, 2026 | Three Months Ended / July 4, 2025 | Six Months Ended / July 3, 2026 | Six Months Ended / July 4, 2025 |
|---|---|---|---|---|
| Cost of sales | 223,533 | 229,848 | 447,199 | 456,453 |
| Gross profit | 359,249 | 334,697 | 724,734 | 666,926 |
| Selling, general and administrative expense | 263,730 | 267,074 | 546,540 | 536,093 |
| Research and development expense | 31,686 | 30,700 | 63,219 | 59,228 |
| Amortization of acquired intangibles | 41,561 | 42,962 | 83,465 | 84,774 |
| Purchase of royalty interest | — | 10,041 | — | 45,818 |
| Restructuring charges | 4,859 | 716 | 7,567 | 4,578 |
| Operating income (loss) | 17,413 | (16,796) | 23,943 | (63,565) |
Item 1. Financial Statements
FAQ
- What is Enovis's R&D?
- Enovis (ENOV) reported R&D of $31.69M in Q2 2026.
- How has Enovis's R&D changed year-over-year?
- Enovis's R&D increased by 3.2% year-over-year, from $30.7M to $31.69M.
- What is the long-term trend for Enovis's R&D?
- Over 4 years (2021 to 2025), Enovis's R&D has grown at a 25.1% compound annual growth rate (CAGR), from $49.09M to $120.33M.
- What does R&D mean?
- Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.
Ask your AI about Enovis's r&d.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude